{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:26:07Z","timestamp":1787736367154,"version":"build-2784847793"},"reference-count":45,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2021,7,16]]},"abstract":"<jats:p>BACKGROUND: Oral squamous cell carcinoma (OSCC) usually originates from oral potentially malignant disorders (OPMD), such as oral leukoplakia (OLK) and oral lichen planus (OLP). Identifying biomarkers for the early diagnosis and evaluation of malignant transformation in OPMD could improve the survival rate of OSCC patients. OBJECTIVE: The present study aimed to screen for potential salivary biomarkers for evaluating the malignant transformation of OPMD. METHODS: Salivary proteases from OLK and OSCC patients or healthy donors and proteases in cultural medium from DOK and Cal-27 cells were detected with a human protease array kit. The concentrations of the salivary Kallikrein 5 (KLK5) and urokinase-type plasminogen activator (uPA) proteases were measured by ELISA. Receiver operating characteristics (ROC) to determine the potential value of these proteases in clinical diagnosis were calculated using SPSS software. Immunohistochemistry was used to detect the KLK5 and uPA expression in the oral organizations. RESULTS: The salivary protease spectrum was different among patients with OLK and OSCC and healthy donors. KLK5 and uPA levels in saliva tended to increase as the disease progressed (healthy &lt; OPMD [OLK and OLP] &lt; OSCC). ROC curves showed the optimum diagnostic cutoffs for KLK5 as a biomarker for OLK, OLP, and OSCC were 5.97, 6.03, and 9.45\u00a0pg\/mL, respectively, while the cutoffs for uPA were 17.19, 17.26, and 20.96\u00a0pg\/mL. Their combined analysis showed a higher sensitivity for the differential diagnosis of disease. Furthermore, higher levels of KLK5 and uPA were observed in OSCC tissues than in OLK and OLP. CONCLUSIONS: Salivary KLK5 and uPA are potential biomarkers for evaluating OLK and OLP malignant transformation and early diagnosis of OSCC.<\/jats:p>","DOI":"10.3233\/cbm-203105","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T17:51:18Z","timestamp":1618941078000},"page":"317-328","source":"Crossref","is-referenced-by-count":14,"title":["Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP"],"prefix":"10.1177","volume":"31","author":[{"given":"Yingzhu","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bomiao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Die","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/CBM-203105_ref1","doi-asserted-by":"crossref","first-page":"eaay3324","DOI":"10.1126\/sciadv.aay3324","article-title":"YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma","volume":"6","author":"Omori","year":"2020","journal-title":"Sci Adv"},{"key":"10.3233\/CBM-203105_ref2","doi-asserted-by":"crossref","first-page":"319489","DOI":"10.1155\/2013\/319489","article-title":"Cancer stem cell markers in head and neck squamous cell carcinoma","volume":"2013","author":"Major","year":"2013","journal-title":"Stem Cells Int"},{"key":"10.3233\/CBM-203105_ref3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13046-018-0760-0","article-title":"Bortezomib enhances radiosensitivity in oral cancer through inducing autophagy-mediated TRAF6 oncoprotein degradation","volume":"37","author":"Wu","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"10.3233\/CBM-203105_ref4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaad.2018.09.060","article-title":"Premalignant and malignant oral mucosal lesions: Clinical and pathological findings","volume":"81","author":"Maymone","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.3233\/CBM-203105_ref5","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.oraloncology.2012.02.025","article-title":"Oral potentially malignant disorders: precising the definition","volume":"48","author":"Sarode","year":"2012","journal-title":"Oral Oncol"},{"key":"10.3233\/CBM-203105_ref6","doi-asserted-by":"crossref","first-page":"102986","DOI":"10.1016\/j.critrevonc.2020.102986","article-title":"Oral potentially malignant disorders: A scoping review of prognostic biomarkers","volume":"153","author":"Mello","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.3233\/CBM-203105_ref7","doi-asserted-by":"crossref","unstructured":"H. Mortazavi, Y. Safi, M. Baharvand, S. Jafari, F. Anbari and S. Rahmani, Oral white lesions: An updated clinical diagnostic decision tree, Dent J (Basel) 7 (2019).","DOI":"10.3390\/dj7010015"},{"key":"10.3233\/CBM-203105_ref8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/jop.12339","article-title":"Malignant transformation of oral leukoplakia: a systematic review of observational studies","volume":"45","author":"Warnakulasuriya","year":"2016","journal-title":"J Oral Pathol Med"},{"key":"10.3233\/CBM-203105_ref9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.oraloncology.2019.07.012","article-title":"Malignant transformation risk of oral lichen planus: A systematic review and comprehensive meta-analysis","volume":"96","author":"Gonzalez-Moles","year":"2019","journal-title":"Oral Oncol"},{"key":"10.3233\/CBM-203105_ref10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ijc.28754","article-title":"Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory","volume":"136","author":"Dionne","year":"2015","journal-title":"Int J Cancer"},{"key":"10.3233\/CBM-203105_ref11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cden.2019.08.004","article-title":"Oral Potentially Malignant Disorders","volume":"64","author":"Wetzel","year":"2020","journal-title":"Dent Clin North Am"},{"key":"10.3233\/CBM-203105_ref12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-3284-3-33","article-title":"Exciting new advances in oral cancer diagnosis: avenues to early detection","volume":"3","author":"Mehrotra","year":"2011","journal-title":"Head Neck Oncol"},{"key":"10.3233\/CBM-203105_ref13","first-page":"256","article-title":"Cancer biomarker discovery and validation","volume":"4","author":"Goossens","year":"2015","journal-title":"Transl Cancer Res"},{"key":"10.3233\/CBM-203105_ref14","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1177\/0022034511420721","article-title":"Whole-saliva proteolysis and its impact on salivary diagnostics","volume":"90","author":"Thomadaki","year":"2011","journal-title":"J Dent Res"},{"key":"10.3233\/CBM-203105_ref15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.advms.2017.11.002","article-title":"Human saliva as a diagnostic material","volume":"63","author":"Chojnowska","year":"2018","journal-title":"Adv Med Sci"},{"key":"10.3233\/CBM-203105_ref16","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3748\/wjg.15.865","article-title":"Diagnostic model of saliva protein finger print analysis of patients with gastric cancer","volume":"15","author":"Wu","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.3233\/CBM-203105_ref17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/pr8003776","article-title":"Proteomic identification of salivary biomarkers of type-2 diabetes","volume":"8","author":"Rao","year":"2009","journal-title":"J Proteome Res"},{"key":"10.3233\/CBM-203105_ref18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1600-0714.2006.00427.x","article-title":"The use of surface-enhanced laser desorption\/ionization time-of-flight mass spectrometry to detect putative breast cancer markers in saliva: a feasibility study","volume":"35","author":"Streckfus","year":"2006","journal-title":"J Oral Pathol Med"},{"key":"10.3233\/CBM-203105_ref19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mehy.2016.02.010","article-title":"Salivary proteomics: A new adjuvant approach to the early diagnosis of familial juvenile systemic lupus erythematosus","volume":"89","author":"Abrao","year":"2016","journal-title":"Med Hypotheses"},{"key":"10.3233\/CBM-203105_ref20","doi-asserted-by":"crossref","unstructured":"R. Sannam Khan, Z. Khurshid, S. Akhbar and S. Faraz Moin, Advances of Salivary Proteomics in Oral Squamous Cell Carcinoma (OSCC) Detection: An Update, Proteomes 4 (2016).","DOI":"10.3390\/proteomes4040041"},{"key":"10.3233\/CBM-203105_ref21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41368-018-0032-z","article-title":"Salivary protease spectrum biomarkers of oral cancer","volume":"11","author":"Feng","year":"2019","journal-title":"Int J Oral Sci"},{"key":"10.3233\/CBM-203105_ref22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/bs.acc.2018.05.002","article-title":"Role of Salivary Biomarkers in Oral Cancer Detection","volume":"86","author":"Khurshid","year":"2018","journal-title":"Adv Clin Chem"},{"key":"10.3233\/CBM-203105_ref23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-051X.2009.01525.x","article-title":"Alterations in the salivary proteome associated with periodontitis","volume":"37","author":"Haigh","year":"2010","journal-title":"J Clin Periodontol"},{"key":"10.3233\/CBM-203105_ref24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/ijos.2015.8","article-title":"Role of saliva proteinase 3 in dental caries","volume":"7","author":"Yang","year":"2015","journal-title":"Int J Oral Sci"},{"key":"10.3233\/CBM-203105_ref25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/bs.acc.2020.04.005","article-title":"Biochemical analysis of oral fluids for disease detection","volume":"100","author":"Khurshid","year":"2021","journal-title":"Adv Clin Chem"},{"key":"10.3233\/CBM-203105_ref26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1055\/s-0040-1716443","article-title":"Salivary IgA as a Useful Biomarker for Dental Caries in Down\u2019s Syndrome Patients: A Systematic Review and Meta-analysis","volume":"14","author":"Hamid","year":"2020","journal-title":"Eur J Dent"},{"key":"10.3233\/CBM-203105_ref27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/978-1-4939-8814-3_20","article-title":"Proteases: Pivot Points in Functional Proteomics","volume":"1871","author":"Verhamme","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.3233\/CBM-203105_ref28","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1074\/jbc.TM118.004156","article-title":"Proteases: History, discovery, and roles in health and disease","volume":"294","author":"Bond","year":"2019","journal-title":"J Biol Chem"},{"key":"10.3233\/CBM-203105_ref29","doi-asserted-by":"crossref","unstructured":"J.S. Yu, Y.T. Chen, W.F. Chiang, Y.C. Hsiao, L.J. Chu, L.C. See, C.S. Wu, H.T. Tu, H.W. Chen, C.C. Chen, W.C. Liao, Y.T. Chang, C.C. Wu, C.Y. Lin, S.Y. Liu, S.T. Chiou, S.L. Chia, K.P. Chang, C.Y. Chien, S.W. Chang, C.J. Chang, J.D. Young, C.C. Pao, Y.S. Chang and L.H. Hartwell, Saliva protein biomarkers to detect oral squamous cell carcinoma in a high-risk population in Taiwan, Proc Natl Acad Sci U S A 113 (2016), 11549\u201311554.","DOI":"10.1073\/pnas.1612368113"},{"key":"10.3233\/CBM-203105_ref30","first-page":"909","article-title":"Protein kinase D3 regulates the expression of the immunosuppressive protein, PDL1, through STAT1\/STAT3 signaling","volume":"56","author":"Cui","year":"2020","journal-title":"Int J Oncol"},{"key":"10.3233\/CBM-203105_ref31","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/1535370217744775","article-title":"Biomarkers: Delivering on the expectation of molecularly driven, quantitative health","volume":"243","author":"Wilson","year":"2018","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.3233\/CBM-203105_ref32","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.00238.2015","article-title":"Tumor cell intravasation","volume":"311","author":"Chiang","year":"2016","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.3233\/CBM-203105_ref33","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.biochi.2015.09.016","article-title":"Proteases decode the extracellular matrix cryptome","volume":"122","author":"Ricard-Blum","year":"2016","journal-title":"Biochimie"},{"key":"10.3233\/CBM-203105_ref34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbcan.2019.05.007","article-title":"Clinical validity of saliva and novel technology for cancer detection","volume":"1872","author":"Kaczor-Urbanowicz","year":"2019","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.3233\/CBM-203105_ref35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.14639\/0392-100X-1598","article-title":"Salivary biomarkers and proteomics: future diagnostic and clinical utilities","volume":"37","author":"Castagnola","year":"2017","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"10.3233\/CBM-203105_ref36","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/nrc1474","article-title":"The emerging roles of human tissue kallikreins in cancer","volume":"4","author":"Borgono","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.3233\/CBM-203105_ref37","first-page":"197","article-title":"Multiple kallikrein (KLK 5, 7, 8, and 10) expression in squamous cell carcinoma of the oral cavity","volume":"24","author":"Pettus","year":"2009","journal-title":"Histol Histopathol"},{"key":"10.3233\/CBM-203105_ref38","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.1074\/jbc.M110.191361","article-title":"Kallikrein-5 promotes cleavage of desmoglein-1 and loss of cell-cell cohesion in oral squamous cell carcinoma","volume":"286","author":"Jiang","year":"2011","journal-title":"J Biol Chem"},{"key":"10.3233\/CBM-203105_ref39","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.1074\/jbc.M115.692640","article-title":"Protease-activated Receptor-2 (PAR-2)-mediated Nf-kappaB Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma","volume":"291","author":"Johnson","year":"2016","journal-title":"J Biol Chem"},{"key":"10.3233\/CBM-203105_ref40","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1517\/14728222.2016.1113260","article-title":"The urokinase-type plasminogen activator (uPA) system as a biomarker and therapeutic target in human malignancies","volume":"20","author":"Su","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"10.3233\/CBM-203105_ref41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z","article-title":"The urokinase-type plasminogen activator system in cancer metastasis: a review","volume":"72","author":"Andreasen","year":"1997","journal-title":"Int J Cancer"},{"key":"10.3233\/CBM-203105_ref42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-94-017-7215-0_10","article-title":"Components of the Plasminogen-Plasmin System as Biologic Markers for Cancer","volume":"867","author":"McMahon","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"10.3233\/CBM-203105_ref43","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12885-017-3349-7","article-title":"Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor \u2013 beta1 (TGF-beta1) and potential effects on migration and invasion","volume":"17","author":"Magnussen","year":"2017","journal-title":"BMC Cancer"},{"key":"10.3233\/CBM-203105_ref44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1471-2407-12-115","article-title":"EMMPRIN\/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression","volume":"12","author":"Lescaille","year":"2012","journal-title":"BMC Cancer"},{"key":"10.3233\/CBM-203105_ref45","doi-asserted-by":"crossref","first-page":"42300","DOI":"10.18632\/oncotarget.15857","article-title":"Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K\/AKT and ERK signaling in esophageal squamous cell carcinoma","volume":"8","author":"Tian","year":"2017","journal-title":"Oncotarget"}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-203105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:08:12Z","timestamp":1777385292000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-203105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":45,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/cbm-203105","relation":{},"ISSN":["1875-8592","1574-0153"],"issn-type":[{"value":"1875-8592","type":"electronic"},{"value":"1574-0153","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,16]]}}}